Stephen M Liebowitz

Title: The Innovations of Stephen M Liebowitz

Introduction

Stephen M Liebowitz is a notable inventor based in Neshanic Station, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of orally administrable solid dosage forms of ribavirin. With a total of 7 patents to his name, Liebowitz continues to push the boundaries of innovation in his field.

Latest Patents

Liebowitz's latest patents include groundbreaking work on orally administrable solid ribavirin dosage forms. One of his patents describes a solid dosage form containing a compacted ribavirin composition that boasts a high tap density of at least 0.6 g/mL. This formulation is notable for its surprisingly rapid disintegration and dissolution rates, ensuring that the ribavirin is substantially free of polymorphic forms. Another patent focuses on the same solid dosage form, emphasizing its advantageous properties and the process for making these innovative dosage forms.

Career Highlights

Stephen M Liebowitz is currently associated with Schering Corporation, where he applies his expertise in pharmaceutical innovations. His work has been instrumental in advancing the formulation of ribavirin, which is crucial for various medical applications.

Collaborations

Throughout his career, Liebowitz has collaborated with esteemed colleagues such as Elliot I Stupak and Imtiaz A Chaudry. These partnerships have contributed to the successful development of his patented innovations.

Conclusion

Stephen M Liebowitz exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the realm of ribavirin dosage forms, highlight the importance of research and development in creating effective medical solutions.